Moderna

As against 86 lakh doses that need to be administered per day, the vaccination rate has been just 40 lakh a day over the past week

The mRNA vaccines by Pfizer and Moderna contain genetic instructions for our cells to make the spike protein of the SARS-CoV-2, which the virus uses to infect and enter the human cells.

Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik

Even 15 weeks after the first dose, eight of 10 people still had detectable germinal centers containing B cells targeting the virus.

The study, published on Thursday in the journal JAMA, recruited 45 healthy male volunteers aged 18 to 50 years scheduled for mRNA COVID-19 vaccination by Pfizer-BioNTech and Moderna.

To evaluate SARS-CoV-2 infant vaccination, the researchers immunised two groups of 8 infant rhesus macaques at 2.2 months of age and 4 weeks later.

Scores of NRIs who had gone to India had taken Covishield as it continues to be the mainstay of India’s Covid-19 vaccination drive

The Centre should consider utilising its position as the monopolistic buyer in the market and pass down the benefit to all people

It is imperative to note that while every university has different rules, we expect many of them will require students to be vaccinated to participate in on-campus study

Passengers arriving in Saudi Arabia must submit a vaccination certificate showing they have received the approved shot, according to guidelines issued by the General Authority of Civil Aviation

Anticipating the shortages, many States including Telangana had recently gone for global tenders

The daily vaccination rate has fallen to 1.3 million doses despite India not exporting the vaccines now

Under the agreement, the biotech unit of Samsung Group will provide the U.S. drugmaker with contract manufacturing organization (CMO) services for its mRNA vaccine. It means that some of the Moderna vaccine would be produced in South Korea.

States like Telangana opting for global tenders to procure vaccine is a pragmatic decision, given the Centre's opaque policy

Nearly 51 per cent of Moderna recipients had full-body symptoms, compared with 48 per cent of people who got the Pfizer/BioNTech shot.